<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To examine pharmacokinetics and tolerance of long term administration of olsalazine (azodisalicylate), increasing doses of the drug were given for one year to 31 patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) and nine patients with Crohn's <z:hpo ids='HP_0002583'>colitis</z:hpo> (CC), refractory to, or intolerant of sulphasalazine, until sustained remission was obtained or a maximum of 4 g/day was reached </plain></SENT>
<SENT sid="1" pm="."><plain>Colonic drug metabolism was studied by equilibrium in vivo dialysis of faeces </plain></SENT>
<SENT sid="2" pm="."><plain>Complete azoreduction occurred in most cases </plain></SENT>
<SENT sid="3" pm="."><plain>Concentrations of <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi>, but not N-<z:chebi fb="9" ids="46887">acetyl</z:chebi>-5-<z:chebi fb="0" ids="27565">aminosalicylic acid</z:chebi>, in faecal dialysates increased dose dependently </plain></SENT>
<SENT sid="4" pm="."><plain>Serum concentrations disclosed no cumulation in the long term and olsalazine was well tolerated, although loose stools occurred transiently in some patients with <z:e sem="disease" ids="C0849867" disease_type="Disease or Syndrome" abbrv="">extensive disease</z:e>: this was associated with a larger proportion of unsplit olsalazine in the faecal dialysates </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> having a high <z:chebi fb="0" ids="15551">prostaglandin E2</z:chebi> concentration (greater than ng/ml) determined by equilibrium dialysis of rectum, were less likely to benefit from treatment </plain></SENT>
<SENT sid="6" pm="."><plain>Olsalazine is a very effective means of delivery of <z:chebi fb="0" ids="6775">5-aminosalicylic acid</z:chebi> to the colonic mucosa in active disease </plain></SENT>
<SENT sid="7" pm="."><plain>Use of the drug in controlled trials may be considered safe even in prolonged high dosage </plain></SENT>
</text></document>